Skip to main content

Table 5 PCV-2 IgG ELISA mean S/P ratios obtained prior to vaccination (3–4 woa) in the 28 farms sampled in 2020 and 2022, grouping the farms in the four stablished scenarios considering PCV-2 detection in both studied years

From: Frequency of PCV-2 viremia in nursery piglets from a Spanish swine integration system in 2020 and 2022 considering PRRSV infection status

Defined scenarios

PCV-2 IgG ELISA S/P ratio before vaccination (3–4 woa)

2020

2022

 

X̅ ± SD

CV (%)

X̅ ± SD

CV (%)

POS20-POS22

0.397 ± 0.197 a A

49.1

0.599 ± 0.372 a A

62.0

POS20-NEG22

0.549 ± 0.203 a AB

37.0

0.686 ± 0.263 a A

38.4

NEG20-POS22

0.628 ± 0.286 a B

45.5

0.476 ± 0.275 b A

57.9

NEG20-NEG22

0.639 ± 0.342 a B

53.4

0.531 ± 0.284 a A

53.6

Total

0.598 ± 0.315

56.6

0.530 ± 0.298

56.1

  1. Different superscript lowercase letters indicate statistically significant differences between years for each scenario, and the uppercase ones indicate statistically significant differences between scenarios in each year (p < 0.05)s
  2. CV: Coefficient of variation; ELISA: Enzyme-Linked ImmunoSorbent Assay; PCV-2: porcine circovirus 2; woa: weeks of age; SD: Standard Deviation